|
Volumn 379, Issue 9812, 2012, Pages 219-
|
Haemopoietic stem-cell transplantation for systemic sclerosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AUTOLOGOUS STEM CELL TRANSPLANTATION;
CLINICAL EFFECTIVENESS;
CLINICAL TRIAL (TOPIC);
DISEASE SEVERITY;
FOLLOW UP;
HEALTH CARE QUALITY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
LETTER;
PRIORITY JOURNAL;
SYSTEMIC SCLEROSIS;
TREATMENT RESPONSE;
EARLY TERMINATION OF CLINICAL TRIAL;
FEMALE;
MALE;
NOTE;
CYCLOPHOSPHAMIDE;
IMMUNOSUPPRESSIVE AGENT;
CYCLOPHOSPHAMIDE;
EARLY TERMINATION OF CLINICAL TRIALS;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
SCLERODERMA, SYSTEMIC;
|
EID: 84856104977
PISSN: 01406736
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/S0140-6736(12)60100-7 Document Type: Letter |
Times cited : (6)
|
References (5)
|